news

English

/

中文

Fontacea was invited to participate in the "ICBC Cup · Shanghai Lingang Innovative Design and Entrep

Fontacea and Thousand Oaks reach strategic cooperation

Fontacea takes action in promoting the R&D and innovation of Chinese biomedicine

Fontacea supports Guzhang through alleviating poverty

"Innovate together to win the future" Fontacea successfully held the launch ceremony in Shenzhen

Mr Yanliang Chu, chairman of Fontacea, signed Dr David Brooks as business consultant in USA

Mr Yanliang Chu, Chairman of Fontacea, signed Dr Timothy P. Coogan as the Medicine Safety Consultant

Senior leaders attended "Innovative Medicine Investment Seminar"

Shandong Fontacea is licensed for anti-IL17A monoclonal antibody from Janssen

Yanliang Chu, welcomes Mark Winnett as Management Consultant to Fontacea

Fontacea shareholder Lei Meng, chairman of Shandong development investment holding group co. LTD

to the end ~